Related Episodes

Episode 169: The Uromigos Paper of the Month – Novel neoadjuvant approaches in UC
Episode 165: Paper of the Month – ENZAMET quality of life data
Paper of the month: what can we learn from R3 ipilimumab/nivolumab in gastric cancer
Episode 162: Debate – Adjuvant nivolumab for bladder cancer
Episode 161: Platinum eligibility in urothelial cancer
Episode 156: ASCO GU 2022 First Line Olaparib and Durvalumab in Bladder Cancer
Episode 152: The Uromigos Paper of the Month – Zr-Pembrolizumab PET Imaging
Episode 151: Bladder Cancer ESMO Guidelines update
Episode 146: Bladder Cancer Christmas Special
Episode 144: Pembrolizumab for bladder cancer